GlycoDisplay Aps: Making biopharmaceuticals more effective
GlycoDisplay Aps, headed by CEO Claus Kristensen will from the spring of 2017 be located at the 10th floor at the Mærsk Tower at the University of Copenhagen. The company is a bright new spin-out from the Danish National Research Foundation Excellence Center for Glycomics, at the university.
The center is world leading within the field of glyco-engineering, which is GlycoDisplay’s core and novel patented technology used to modify sugar structures on glycoproteins to develop novel biopharmaceuticals.
20 September 2018
Bioagora 2018 (Copenhagen)
19 September 2018
STZ OcuTox: Drug development know-how
12 September 2018
Good industry performance lifted spirits in the HealthBIO conference